DRMA - Balance Sheet - Dermata Therapeutics, Inc.

Current Liabilities	1.97 M
Accounts Payable	808 K
Short-Term Debt	0
Other Current Liabilities	1.16 M
Non-Current Liabilities	1.16 B
Long-Term Debt	0
Other Non-Current Liabilities	1.16 B

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	3.2	7.4	6.2	10.8	0.5	2.0
Short Term Investments	0	0	0	0	0	0
Receivables	0	8.36 K	12.6 K	0	0	0
Inventory	0	0	0	0	0	0
Other Current Assets	0	0.5	0.7	0.8	75.1 K	73.7 K
Total Current Assets	3.5	8.0	6.9	11.6	0.6	2.1
PP&E	0	0	0	0	0	322
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0
Other Long Term Assets	0	0	0	55.7 K	0	0
Other Assets	0	0	703.2	55.7 K	0	0
Total Assets	3.5	8.0	6.9	11.6	0.6	2.1
LIABILITIES
Accounts Payable	0.8	0.9	0.5	0.5	0.1	0.3
Short Term Debt	0	0	0	0	3.5	0.7
Other Current Liabilities	1.2	0.8	0.4	1.0	0.1	0.7
Total Current Liabilities	2.0	1.6	0.9	1.5	3.8	1.7
Long Term Debt	0	0	0	0	0	0.6
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	1 164.8	0	0	0	0	0
Total Liabilities	2.0	1.6	0.9	1.5	3.8	2.3
EQUITY
Common Stock	252	393	1.23 K	833	2.4	2.4
Retained Earnings	(65 675.3)	(53.4)	(45.6)	(36.0)	(28.1)	(24.8)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	(53.0)	(49.5)
Total Equity	1 561.1	6.4	6.0	10.1	(28.1)	(24.8)
Total Liabilities and Equity	3.5	8.0	6.9	11.6	3.8	2.3
SHARES OUTSTANDING
Common Shares Outstanding	1.5	0.2	0.7	0.5	0.5	0.5

Free